Reaction
Manufacturing Product Shipping Issue reporting signals
As of the last recalculation, Manufacturing Product Shipping Issue appears in 533 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is IOHEXOL (PRR 14.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Iohexol | 3 | 14.2 | 14.2 |
| Ixekizumab | 13 | 14.0 | 14.0 |
| Glecaprevir And Pibrentasvir | 3 | 10.7 | 10.7 |
| Onabotulinumtoxina | 20 | 10.5 | 10.5 |
| Velpatasvir And Sofosbuvir | 3 | 9.2 | 9.2 |
| Vigabatrin | 3 | 8.1 | 8.1 |